Mitochondrial biology and neurological diseases

Current Neuropharmacology

Volumn 14, Issue 2, 2016, Pages 143-154

  Arun, Siddharth ^a   Liu, Lei ^a   Donmez, Gizem ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Huntington's disease; Mitochondrial dysfunction; Neurodegeneration; Parkinson's disease

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; AUXILIN; CLATHRIN ASSEMBLY PROTEIN; DJ 1 PROTEIN; HUNTINGTIN; INITIATION FACTOR 4 GAMMA 1; LEUCINE RICH REPEAT KINASE 2; MANGANESE SUPEROXIDE DISMUTASE; MITOCHONDRIAL DNA; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; MITOCHONDRIAL PROTEIN; PRESENILIN 1; PRESENILIN 2; PROTEIN ATP13A2; PROTEIN ATP6AP2; PROTEIN FBXO7; PROTEIN PARK2; PROTEIN PINK1; PROTEIN PLA2G6; PROTEIN VPS35; REACTIVE OXYGEN METABOLITE; RESVERATROL; SIRTUIN 3; SYNAPTOJANIN; TAU PROTEIN; UBIQUINONE; UNCLASSIFIED DRUG; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE);

ALZHEIMER DISEASE; APOPTOSIS; DEGENERATIVE DISEASE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA DAMAGE; HUMAN; HUNTINGTON CHOREA; MITOCHONDRIAL GENETICS; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; NERVE DEGENERATION; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PROTEIN AGGREGATION; PROTEIN PHOSPHORYLATION; RESPIRATORY CHAIN; REVIEW; TRANSCRIPTION REGULATION; UBIQUITINATION; ANIMAL; GENETICS; METABOLISM; MITOCHONDRIAL DYNAMICS; MUTATION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; APOPTOSIS; DNA, MITOCHONDRIAL; ELECTRON TRANSPORT COMPLEX I; HUMANS; MITOCHONDRIA; MITOCHONDRIAL DYNAMICS; MUTATION; NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS;

EID: 84960080248     PISSN: 1570159X     EISSN: 18756190     Source Type: Journal    
DOI: 10.2174/1570159X13666150703154541     Document Type: Review

References (99)

1. Verstraeten, A., Theuns, J. and Van Broeckhoven, C. Progress in unraveling the genetic etiology of Parkinson disease in a genomic era. Trends Genet., 2015, 31(3), 140-149. http://dx.doi.org/10.1016/j.tig.2015.01.004.
2. Mahalingam, S. and Levy, L.M. Genetics of Huntington disease. Am. J. Neuroradiol., 2014, 35(6), 1070-2. http://dx.doi.org/10.3174/ajnr.A3772.
3. Gray, M.W. Mitochondrial evolution. Cold Spring Harb. Perspect Biol., 2012, 4(9), a011403. http://dx.doi.org/10.1101/cshperspect.a011403.
4. Richardson, J.R., Caudle, W.M., Guillot, T.S., Watson, J.L., Nakamaru-Ogiso, E., Seo, B.B., Sherer, T.B., Greenamyre, J.T., Yagi, T., Matsuno-Yagi, A., Miller, G.W. Obligatory role for complex I inhibition in the dopaminergic neurotoxicity of 1- methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP). Toxicol. Sci., 2007, 95(1), 196-204. http://dx.doi.org/10.1093/toxsci/kfl133.
5. Swomley, A.M., Förster, S., Keeney, J.T., Triplett, J., Zhang, Z., Sultana R., Butterfield, D.A. Abeta, oxidative stress in Alzheimer disease: evidence based on proteomics studies. Biochim. Biophys. Acta, 2014, 1842(8), 1248-57. http://dx.doi.org/10.1016/j.bbadis.2013.09.015.
6. Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., Shimizu, N. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature, 1998, 392(6676), 605-8. http://dx.doi.org/10.1038/33416.
7. Valente, E.M., Abou-Sleiman, P.M., Caputo, V., Muqit, M.M., Harvey, K., Gispert S., Ali, Z., Del Turco, D., Bentivoglio, A.R., Healy, D.G., Albanese, A., Nussbaum, R., González-Maldonado, R., Deller, T., Salvi, S., Cortelli, P, Gilks W.P., Latchman, D.S., Harvey, R.J., Dallapiccola, B., Auburger, G., Wood, N.W.Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science, 2004, 304(5674) 1158-60. http://dx.doi.org/10.1126/science.1096284.
8. Funayama, M., Hasegawa, K., Kowa, H., Saito, M., Tsuji, S., Obata, F. A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2-q13.1. Ann. Neurol., 2002, 51(3), 296-301. http://dx.doi.org/10.1002/ana.10113.
9. Humphrey, D.M., Parsons, R.B., Ludlow, Z.N., Riemensperger, T, Esposito, G., Verstreken, P., Jacobs, H.T., Birman, S., Hirth, F. Alternative oxidase rescues mitochondria-mediated dopaminergic cell loss in Drosophila. Hum. Mol. Genet., 2012, 21(12), 2698-712. http://dx.doi.org/10.1093/hmg/dds096.
10. Bloom, G.S. Amyloid-beta and tau: the trigger and bullet in Alzheimer disease pathogenesis. JAMA Neurol., 2014, 71(4), 505-8. http://dx.doi.org/10.1001/jamaneurol.2013.5847.
11. Delabio, R., Rasmussen, L., Mizumoto, I., Viani, G.A., Chen, E., Villares, J., Costa, I.B., Turecki, G., Linde, S.A., Smith, M.C., Payão, S.L. PSEN1 and PSEN2 gene expression in Alzheimer's disease brain: a new approach. J. Alzheimers Dis., 2014, 42(3), 757-60.
12. No authors listed. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group. Cell, 1993, 72(6), 971-83. http://dx.doi.org/10.1016/0092-8674(93)90585-E
13. Burgunder, J.M. Genetics of Huntington's disease and related disorders. Drug Discov. Today, 2014, 19(7), 985-9. http://dx.doi.org/10.1016/j.drudis.2014.03.005.
14. Xu, W., Tan, L. and Yu, J.T. The link between the SNCA gene and parkinsonism. Neurobiol. Aging, 2015, 36(3), 1505-1518. http://dx.doi.org/10.1016/j.neurobiolaging.2014.10.042.
15. Nuytemans, K., Theuns, J., Cruts, M., Van Broeckhoven, C. Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update. Hum. Mutat., 2010, 31(7), 763-80. http://dx.doi.org/10.1002/humu.21277.
16. Yang, X., and Xu, Y. Mutations in the ATP13A2 gene and Parkinsonism: a preliminary review. Biomed. Res. Int., 2014, 2014, 37, 1256. http://dx.doi.org/10.1371/journal.pone.0101392.
17. Chen, C.M., Chen, I.C., Huang, Y.C., Juan, H.F., Chen, Y.L., Chen, YC, Lin, C.H., Lee, L.C., Lee, C.M., Lee-Chen, G.J., Lai, Y.J., Wu, Y.R. FBXO7 Y52C polymorphism as a potential protective factor in Parkinson's disease. PLoS One, 2014, 9(7), e101392. http://dx.doi.org/10.1371/journal.pone.0101392.
18. Illingworth, M.A., Meyer, E., Chong, W.K., Manzur, A.Y., Carr, L.J., Younis, R., Hardy, C., McDonald, F., Childs, A.M., Stewart, B., Warren, D., Kneen, R., King, M.D., Hayflick, S.J., Kurian, M.A. PLA2G6-associated neurodegeneration (PLAN): further expansion of the clinical, radiological and mutation spectrum associated with infantile and atypical childhood-onset disease. Mol. Genet. Metab., 2014, 112(2), 183-9. http://dx.doi.org/10.1016/j.ymgme.2014.03.008.
19. Tsika, E., Glauser, L., Moser, R., Fiser, A., Daniel, G., Sheerin U.M., Lees, A., Troncoso, J.C., Lewis, P.A., Bandopadhyay, R., Schneider, B.L., Moore, D.J. Parkinson's disease-linked mutations in VPS35 induce dopaminergic neurodegeneration. Hum. Mol. Genet, 2014, 23(17), 4621-38. http://dx.doi.org/10.1093/hmg/ddu178.
20. Chartier-Harlin, M.C., Dachsel, J.C., Vilariño-Güell, C., Lincoln, S.J., Leprêtre, F., Hulihan, M.M., Kachergus, J., Milnerwood, A.J., Tapia, L., Song, M.S., Le Rhun, E., Mutez, E., Larvor, L., Duflot, A., Vanbesien-Mailliot, C., Kreisler, A., Ross, O.A., Nishioka, K., Soto-Ortolaza, A.I., Cobb, S.A., Melrose, H.L., Behrouz, B., Keeling, B.H., Bacon, J.A., Hentati, E., Williams, L., Yanagiya, A., Sonenberg, N., Lockhart, P.J., Zubair, A.C., Uitti, R.J., Aasly, J.O., Krygowska-Wajs, A., Opala, G., Wszolek, Z.K., Frigerio, R., Maraganore, D.M., Gosal, D., Lynch, T., Hutchinson, M., Bentivoglio A.R., Valente, E.M., Nichols, W.C., Pankratz, N., Foroud, T., Gibson R.A., Hentati, F., Dickson, D.W., Destée, A., Farrer, M.J. Translation initiator EIF4G1 mutations in familial Parkinson disease. Am. J. Hum. Genet., 2011, 89(3), 398-406. http://dx.doi.org/10.1016/j.ajhg.2011.08.009.
21. Bonifati, V. Genetics of Parkinson's disease--state of the art. Parkinson. Relat. Disord., 2014, 20 1, S23-8. http://dx.doi.org/10.1016/S1353-8020(13)70009-9.
22. Kanda, A., Noda K., and Ishida, S. ATP6AP2/(pro)renin receptor contributes to glucose metabolism via stabilizing the pyruvate dehydrogenase E1 beta subunit. J. Biol. Chem., 2015, 290, 9690-700. http://dx.doi.org/10.1074/jbc.M114.626713.
23. Jakobs, B.S., van den Heuvel, L.P., Smeets, R.J., de Vries, M.C., Hien, S., Schaible, T., Smeitink, J.A., Wevers, R.A., Wortmann, S.B., Rodenburg, R.J. A novel mutation in COQ2 leading to fatal infantile multisystem disease. J. Neurol. Sci., 2013, 326(1-2), 24-8. http://dx.doi.org/10.1016/j.jns.2013.01.004.
24. Vilariño-Güell, C., Rajput, A., Milnerwood, A.J., Shah, B., Szu-Tu, C, Trinh, J., Yu, I., Encarnacion, M., Munsie, L.N., Tapia, L., Gustavsson, E.K., Chou, P., Tatarnikov, I., Evans, D.M., Pishotta, F.T., Volta, M., Beccano-Kelly, D., Thompson, C., Lin, M.K, Sherman H.E., Han, H.J., Guenther B.L., Wasserman, W.W., Bernard V, Ross C.J., Appel Cresswell, S., Stoessl, A.J., Robinson, C.A., Dickson, D.W., Ross, O.A., Wszolek, Z.K., Aasly, J.O., Wu, R.M., Hentati, F, Gibson, R.A., McPherson, P.S., Girard, M., Rajput, M., Rajput, A.H., Farrer, M.J. DNAJC13 mutations in Parkinson disease. Hum. Mol. Genet., 2014, 23(7), 1794-801.
25. Alonso, V.M.E., Lopez-Lopez, M., and Yescas-Gomez, P. Genetics of Alzheimer's disease. Arch. Med. Res., 2012, 43(8), 622-31. http://dx.doi.org/10.1016/j.arcmed.2012.10.017.
26. Karch, C.M., Cruchaga, C. and Goate, A.M. Alzheimer's disease genetics: from the bench to the clinic. Neuron, 2014, 83(1), 11-26. http://dx.doi.org/10.1016/j.neuron.2014.05.041.
27. Zheng, Z. and Diamond, M.I. Huntington disease and the huntingtin protein. Prog. Mol. Biol. Transl. Sci., 2012, 107, 189-214. http://dx.doi.org/10.1016/B978-0-12-385883-2.00010-2.
28. Parkinson, G.M., Dayas, C.V. and Smith D.W. Increased mitochondrial DNA deletions in substantia nigra dopamine neurons of the aged rat. Curr. Aging Sci., 2014, 7(3), 155-60. http://dx.doi.org/10.2174/1874609808666150122150850.
29. Sanders, L.H., McCoy, J., Hu, X., Mastroberardino, P.G., Dickinson, B.C., Chang, C.J., Chu, C.T., Van Houten, B., Greenamyre, J.T. Mitochondrial DNA damage: molecular marker of vulnerable nigral neurons in Parkinson's disease. Neurobiol. Dis., 2014, 70, 214-23. http://dx.doi.org/10.1016/j.nbd.2014.06.014.
30. Lin, M.T., Cantuti-Castelvetri, I., Zheng, K., Jackson, K.E., Tan, Y.B., Arzberger, T., Lees, A.J., Betensky, R.A., Beal, M.F., Simon, D.K. Somatic mitochondrial DNA mutations in early Parkinson and incidental Lewy body disease. Ann. Neurol., 2012, 71(6), 850-4. http://dx.doi.org/10.1002/ana.23568.
31. Simon, D.K., Pankratz, N., Kissell, D.K., Pauciulo M.W., Halter, C.A., Rudolph, A., Pfeiffer, R.F., Nichols, W.C., Foroud, T. Maternal inheritance and mitochondrial DNA variants in familial Parkinson's disease. BMC Med. Genet., 2010, 11, 53. http://dx.doi.org/10.1186/1471-2350-11-53.
32. Andalib, S., Vafaee, M.S. and Gjedde, A. Parkinson's disease and mitochondrial gene variations: a review. J. Neurol. Sci., 2014, 346(1-2), 11-9. http://dx.doi.org/10.1016/j.jns.2014.07.067.
33. Coskun, P., Wyrembak, J., Schriner, S.E., Chen, H.W., Marciniack, C, Laferla, F., Wallace, D.C. A mitochondrial etiology of Alzheimer and Parkinson disease. Biochim. Biophys. Acta, 2012, 1820(5), 553-64. http://dx.doi.org/10.1016/j.bbagen.2011.08.008.
34. Hudson, G, Nalls, M., Evans, J.R., Breen, D.P., Winder-Rhodes, S., Morrison, K.E., Morris, H.R., Williams-Gray, C.H., Barker, R.A., Singleton, A.B., Hardy, J., Wood, N.E., Burn, D.J., Chinnery, P.F. Two-stage association study and meta-analysis of mitochondrial DNA variants in Parkinson disease. Neurology, 2013, 80(22), 2042-8. http://dx.doi.org/10.1212/WNL.0b013e318294b434.
35. Iacobazzi, V., Castegna, A., Infantino, V., Andria, G. Mitochondrial DNA methylation as a next-generation biomarker and diagnostic tool. Mol. Genet. Metab., 2013, 110(1-2), 25-34. http://dx.doi.org/10.1016/j.ymgme.2013.07.012.
36. Gerschütz, A., Heinsen, H., Grünblatt, E., Wagner, A.K., Bartl, J., Meissner, C., Fallgatter, A.J., Al-Sarraj, S., Troakes, C., Ferrer, I., Arzberger, T., Deckert, J., Riederer, P., Fischer, M., Tatschner, T., Monoranu, C.M. Neuron-specific mitochondrial DNA deletion levels in sporadic Alzheimer's disease. Curr. Alzheimer Res., 2013, 10(10), 1041-6. http://dx.doi.org/10.2174/15672050113106660166.
37. Yan, M.H., Wang, X. and Zhu, X. Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease. Free Radic. Biol. Med., 2013, 62, 90-101. http://dx.doi.org/10.1016/j.freeradbiomed.2012.11.014.
38. Phillips, N.R., Simpkins, J.W. and Roby, R.K. Mitochondrial DNA deletions in Alzheimer's brains: a review. Alzheimers Dement., 2014, 10(3), 393-400. http://dx.doi.org/10.1016/j.jalz.2013.04.508.
39. Fachal, L., Mosquera Miguel, A., Pastor, P., Ortega Cubero, S., Lorenzo, E., Oterino Durán, A., Toriello, M., Quintáns, B., Camiña Tato, M., Sesar, A., Vega, A., Sobrido, M.J., Salas, A. No evidence of association between common European mitochondrial DNA variants in Alzheimer, Parkinson, and migraine in the Spanish population. Am. J. Med. Genet. B. Neuropsychiatr. Genet., 2015, 168B(1), 54-65. http://dx.doi.org/10.1002/ajmg.b.32276.
40. Hudson, G., Sims R., Harold, D., Chapman, J., Hollingworth, P., Gerrish, A., Russo G, Hamshere, M., Moskvina, V., Jones N, Thomas, C., Stretton, A., Holmans, P.A., O'Donovan, M.C., Owen, M.J., Williams J., Chinnery, P.F. No consistent evidence for association between mtDNA variants and Alzheimer disease. Neurology, 2012, 78(14), 1038-42. http://dx.doi.org/10.1212/WNL.0b013e31824e8f1d
41. Arning, L., Haghikia, A., Taherzadeh-Fard, E., Saft, C., Andrich, J., Pula, B., Höxtermann, S., Wieczorek, S., Akkad, D.A., Perrech, M., Gold, R., Epplen, J.T., Chan, A. Mitochondrial haplogroup H correlates with ATP levels and age at onset in Huntington disease. J. Mol. Med. (Berl)., 2010, 88(4), 431-6. http://dx.doi.org/10.1007/s00109-010-0589-2.
42. Mancuso, M., Kiferle, L., Petrozzi, L., Nesti, C, Rocchi, A., Ceravolo R., Orsucci, D., Maluccio, M.R., Bonuccelli, U., Filosto, M., Siciliano, G., Murri, L. Mitochondrial DNA haplogroups do not influence the Huntington's disease phenotype. Neurosci. Lett., 2008, 444(1), 83-6. http://dx.doi.org/10.1016/j.neulet.2008.08.013.
43. Wang, J.Q., Chen, Q., Wang, X., Wang, Q.C., Wang, Y., Cheng, H.P., Guo, C., Sun, Q., Chen, Q., Tang, T.S. Dysregulation of mitochondrial calcium signaling and superoxide flashes cause mitochondrial genomic DNA damage in Huntington disease. J. Biol. Chem., 2013, 288(5), 3070-84. http://dx.doi.org/10.1074/jbc.M112.407726.
44. Siddiqui, A., Rivera-Sánchez, S., Castro, M.R., Acevedo-Torres, K., Rane, A., Torres-Ramos, C.A., Nicholls, D.G., Andersen, J.K., Ayala-Torres, S. Mitochondrial DNA damage is associated with reduced mitochondrial bioenergetics in Huntington's disease. Free Radic. Biol. Med., 2012, 53(7), 1478-88. http://dx.doi.org/10.1016/j.freeradbiomed.2012.06.008.
45. Xun, Z., Rivera-Sánchez, S., Ayala-Peña, S., Lim, J., Budworth, H., Skoda, E.M., Robbins, P.D., Niedernhofer, L.J., Wipf, P., McMurray, C.T. Targeting of XJB-5-131 to mitochondria suppresses oxidative DNA damage and motor decline in a mouse model of Huntington's disease. Cell Rep., 2012, 2(5), 1137-42. http://dx.doi.org/10.1016/j.celrep.2012.10.001.
46. Lin, M.T., Beal, M.F. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature, 2006, 443(7113), 787-95. http://dx.doi.org/10.1038/nature05292.
47. Wood-Kaczmar, A., Gandhi, S., Yao, Z., Abramov, A.Y., Miljan, EA, Keen, G., Stanyer, L., Hargreaves, I., Klupsch, K., Deas, E., Downward, J., Mansfield, L., Jat, P., Taylor, J., Heales, S., Duchen, M.R., Latchman, D., Tabrizi, S.J., Wood, N.W. PINK1 is necessary for long term survival and mitochondrial function in human dopaminergic neurons. PLoS One, 2008, 3(6), e2455. http://dx.doi.org/10.1371/journal.pone.0002455.
48. Westermann, B. Bioenergetic role of mitochondrial fusion and fission. Biochim. Biophys. Acta, 2012, 1817(10), 1833-8. http://dx.doi.org/10.1016/j.bbabio.2012.02.033.
49. Itoh, K., Nakamura, K., Iijima, M., Sesaki, H. Mitochondrial dynamics in neurodegeneration. Trends Cell Biol., 2013, 23(2), 64-71. http://dx.doi.org/10.1016/j.tcb.2012.10.006.
50. Zhao, J., Liu, T., Jin S, Wang X, Qu, M., Uhlén, P., Tomilin, N., Shupliakov, O., Lendahl, U., Nistér, M. Human MIEF1 recruits Drp1 to mitochondrial outer membranes and promotes mitochondrial fusion rather than fission. EMBO J, 2011, 30(14), 2762-78. http://dx.doi.org/10.1038/emboj.2011.198.
51. Perier, C. and Vila, M. Mitochondrial biology and Parkinson's disease. Cold Spring Harb. Perspect. Med., 2012, 2(2), a009332. http://dx.doi.org/10.1101/cshperspect.a009332.
52. Chen, H., Detmer, S.A., Ewald, A.J., Griffin EE, Fraser, S.E., Chan, D.C. Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development. J. Cell Biol., 2003, 160(2), 189-200. http://dx.doi.org/10.1083/jcb.200211046.
53. Iijima-Ando, K., Sekiya, M., Maruko-Otake, A., Ohtake, Y., Suzuki, E., Lu, B., Iijima, K.M. Loss of axonal mitochondria promotes tau-mediated neurodegeneration and Alzheimer's diseaserelated tau phosphorylation via PAR-1. PLoS Genet., 2012, 8(8), e1002918. http://dx.doi.org/10.1371/journal.pgen.1002918.
54. Ashrafi, G., Schlehe, J.S., LaVoie, M.J., Schwarz, T.L. Mitophagy of damaged mitochondria occurs locally in distal neuronal axons and requires PINK1 and Parkin. J. Cell Biol., 2014, 206(5), 655-70. http://dx.doi.org/10.1083/jcb.201401070.
55. Yang, Y., Ouyang, Y., Yang, L., Beal, M.F., McQuibban, A., Vogel, H., Lu, B. Pink1 regulates mitochondrial dynamics through interaction with the fission/fusion machinery. Proc. Natl. Acad. Sci. U. S. A., 2008, 105(19), 7070-5. http://dx.doi.org/10.1073/pnas.0711845105.
56. Dagda, R.K., Cherra, S.J. 3rd, Kulich, S.M., Tandon, A., Park, D., Chu, C.T. Loss of PINK1 function promotes mitophagy through effects on oxidative stress and mitochondrial fission. J. Biol. Chem., 2009, 284(20), 13843-55. http://dx.doi.org/10.1074/jbc.M808515200.
57. Shirendeb, U., Reddy A.P., Manczak, M., Calkins, M.J., Mao, P., Tagle D.A., Reddy, P.H. Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damage. Hum. Mol. Genet., 2011, 20(7), 1438-55. http://dx.doi.org/10.1093/hmg/ddr024.
58. Deng, H., Dodson, M.W., Huang, H., Guo, M. The Parkinson's disease genes pink1 and parkin promote mitochondrial fission and/or inhibit fusion in Drosophila. Proc. Natl. Acad. Sci. U. S. A., 2008, 105(38), 14503-8. http://dx.doi.org/10.1073/pnas.0803998105.
59. Xie, W., and Chung, K.K. Alpha-synuclein impairs normal dynamics of mitochondria in cell and animal models of Parkinson's disease. J. Neurochem., 2012, 122(2), 404-14. http://dx.doi.org/10.1111/j.1471-4159.2012.07769.x
60. Rojas-Charry, L., Cookson, M.R., Niño, A., Arboleda, H., Arboleda, G. Downregulation of Pink1 influences mitochondrial fusion-fission machinery and sensitizes to neurotoxins in dopaminergic cells. Neurotoxicology, 2014, 44, 140-8. http://dx.doi.org/10.1016/j.neuro.2014.04.007.
61. Wang, X., Su, B., Lee, H.G., Li, X., Perry, G., Smith, M.A., Zhu, X. Impaired balance of mitochondrial fission and fusion in Alzheimer's disease. J. Neurosci., 2009, 29(28), 9090-103. http://dx.doi.org/10.1523/JNEUROSCI.1357-09.2009.
62. Selfridge, J.E., E. L., Lu, J., Swerdlow, R.H. Role of mitochondrial homeostasis and dynamics in Alzheimer's disease. Neurobiol. Dis., 2013, 51, 3-12. http://dx.doi.org/10.1016/j.nbd.2011.12.057.
63. Manczak, M. and Reddy, P.H. Abnormal interaction between the mitochondrial fission protein Drp1 and hyperphosphorylated tau in Alzheimer's disease neurons: implications for mitochondrial dysfunction and neuronal damage. Hum. Mol. Genet., 2012, 21(11), 2538-47. http://dx.doi.org/10.1093/hmg/dds072.
64. Ziv, I., Melamed, E., Nardi, N., Luria, D., Achiron, A., Offen, D., Barzilai, A. Dopamine induces apoptosis-like cell death in cultured chick sympathetic neurons--a possible novel pathogenetic mechanism in Parkinson's disease. Neurosci. Lett., 1994, 170(1), 136-40. http://dx.doi.org/10.1016/0304-3940(94)90258-5.
65. Indran, I.R., Tufo, G., Pervaiz, S., Brenner, C. Recent advances in apoptosis, mitochondria and drug resistance in cancer cells. Biochim. Biophys. Acta, 2011, 1807(6), 735-45. http://dx.doi.org/10.1016/j.bbabio.2011.03.010.
66. Perier, C., Tieu, K., Guégan, C., Caspersen, C., Jackson-Lewis, V., Carelli, V., Martinuzzi, A., Hirano, M., Przedborski, S., Vila, M. Complex I deficiency primes Bax-dependent neuronal apoptosis through mitochondrial oxidative damage. Proc. Natl. Acad. Sci. U. S. A., 2005, 102(52), 19126-31. http://dx.doi.org/10.1073/pnas.0508215102.
67. Wang, X.J., Cao, Q., Zhang, Y., Su, X.D. Activation and regulation of caspase-6 and its role in neurodegenerative diseases. Annu. Rev. Pharmacol. Toxicol., 2015, 55, 553-72. http://dx.doi.org/10.1146/annurev-pharmtox-010814-124414.
68. Luo, D.J., Feng, Q., Wang, Z.H., Sun, D.S., Wang, Q., Wang, J.Z., Liu GP Knockdown of phosphotyrosyl phosphatase activator induces apoptosis via mitochondrial pathway and the attenuation by simultaneous tau hyperphosphorylation. J. Neurochem., 2014, 130(6), 816-25. http://dx.doi.org/10.1111/jnc.12761.
69. Sunita, M., Masahide, O., Masashi, T., Jun, H., and Yasuyoshi, S. Mitochondrial impairment triggers cytosolic oxidative stress and cell death following proteasome inhibition. Sci. Rep., 2014, 4, 5896.
70. Chanvitayapongs, S., Draczynska-Lusiak, B., and Sun, A.Y. Amelioration of oxidative stress by antioxidants and resveratrol in PC12 cells. Neuroreport, 1997, 8(6), 1499-502. http://dx.doi.org/10.1097/00001756-199704140-00035.
71. Kang, M.H., Kawai, Y., Naito, M., Osawa, T. Dietary defatted sesame flour decreases susceptibility to oxidative stress in hypercholesterolemic rabbits. J. Nutr., 1999, 129(10), 1885-90.
72. Cottrell, D.A., Borthwick, G.M., Johnson, M.A., Ince, P.G., Turnbull, D.M. The role of cytochrome c oxidase deficient hippocampal neurones in Alzheimer's disease. Neuropathol. Appl. Neurobiol., 2002, 28(5), 390-6. http://dx.doi.org/10.1046/j.1365-2990.2002.00414.x
73. Tabrizi, S.J., Cleeter, M.W., Xuereb, J., Taanman, J.W., Cooper, J.M., Schapira, A.H. Biochemical abnormalities and excitotoxicity in Huntington's disease brain. Ann. Neurol., 1999, 45(1), 25-32. http://dx.doi.org/10.1002/1531-8249(199901)45:1<25::AIDART6> 3.0.CO;2-E
74. Kincaid, B., and Bossy-Wetzel, E. Forever young: SIRT3 a shield against mitochondrial meltdown, aging, and neurodegeneration. Front. Aging Neurosci., 2013, 5, 48. http://dx.doi.org/10.3389/fnagi.2013.00048.
75. Langston, J.W., Ballar, D P., Tetrud, J.W., Irwin, I. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science, 1983, 219(4587), 979-80. http://dx.doi.org/10.1126/science.6823561.
76. Brice, A. Genetics of Parkinson's disease: LRRK2 on the rise. Brain, 2005, 128(Pt 12), 2760-2. http://dx.doi.org/10.1093/brain/awh676.
77. Oliveras-Salvá, M., Macchi, F., Coessens, V., Deleersnijder, A., Gérard M., Van der Perren, A., Van den Haute, C., Baekelandt, V. Alpha-synuclein-induced neurodegeneration is exacerbated in PINK1 knockout mice. Neurobiol. Aging, 2014, 35(11), 2625-36. http://dx.doi.org/10.1016/j.neurobiolaging.2014.04.032.
78. Devi, L., Raghavendran, V., Prabhu, B.M., Avadhani, N.G., Anandatheerthaverada, H.K. Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain. J. Biol. Chem., 2008, 283(14), 9089-100. http://dx.doi.org/10.1074/jbc.M710012200.
79. Parganlija, D., Klinkenberg, M., Domínguez-Bautista, J., Hetzel, M., Gispert, S., Chimi, M.A., Dröse, S., Mai, S., Brandt, U., Auburger, G., Jendrach, M. Loss of PINK1 impairs stress-induced autophagy and cell survival. PLoS One, 2014, 9(4), e95288. http://dx.doi.org/10.1371/journal.pone.0095288.
80. Clarimon, J., Kulisevsky, J. Parkinson's disease: from genetics to clinical practice. Curr. Genom., 2013, 14(8), 560-7. http://dx.doi.org/10.2174/1389202914666131210212305.
81. Romaní-Aumedes, J., Canal, M., Martín-Flores, N., Sun, X., Pérez- Fernández, V., Wewering, S., Fernández-Santiago, R, Ezquerra, M., Pont-Sunyer, C., Lafuente, A., Alberch, J., Luebbert, H., Tolosa, E, Levy, O.A., Greene, L.A., Malagelada, C. Parkin loss of function contributes to RTP801 elevation and neuro degeneration in Parkinson's disease. Cell Death Dis., 2014, 5, e1364. http://dx.doi.org/10.1038/cddis.2014.333.
82. Hindle, S.J. and Elliott, C.J. Spread of neuronal degeneration in a dopaminergic, Lrrk-G2019S model of Parkinson disease. Autophagy, 2013, 9(6), 936-8. http://dx.doi.org/10.4161/auto.24397.
83. Tong, Y., Yamaguchi, H., Giaime, E., Boyle, S., Kopan, R., Kellehe, R.J. 3rd, Shen, J. Loss of leucine-rich repeat kinase 2 causes impairment of protein degradation pathways, accumulation of alpha-synuclein, and apoptotic cell death in aged mice. Proc. Natl. Acad. Sci. U. S. A., 2010, 107(21), 9879-84. http://dx.doi.org/10.1073/pnas.1004676107.
84. Gan, X., Wu, L., Huang, S., Zhong, C., Shi, H., Li, G., Yu, H., Howard, S., Xi, C. J., Yan, S.S. Oxidative stress-mediated activation of extracellular signal-regulated kinase contributes to mild cognitive impairment-related mitochondrial dysfunction. Free Radic. Biol. Med., 2014, 75, 230-40. http://dx.doi.org/10.1016/j.freeradbiomed.2014.07.021.
85. Zhao, Y. and Zhao, B. Oxidative stress and the pathogenesis of Alzheimer's disease. Oxid. Med. Cell Longev., 2013, 2013, 316523.
86. Shi, C., Zhu, X., Wang, J., Long, D. Intromitochondrial IkappaB/NF-kappaB signaling pathway is involved in amyloid beta peptideinduced mitochondrial dysfunction. J. Bioenerg. Biomembr., 2014, 46(5), 371-6. http://dx.doi.org/10.1007/s10863-014-9567-7.
87. Mattson, M.P. and Camandola, S. NF-kappa B in neuronal plasticity and neurodegenerative disorders. J. Clin. Invest., 2001, 107(3), 247-54. http://dx.doi.org/10.1172/JCI11916.
88. Pimentel, C., Batista-Nascimento, L., Rodrigues-Pousada, C., Menezes, R.A. Oxidative stress in Alzheimer's and Parkinson's diseases: insights from the yeast Saccharomyces cerevisiae. Oxid. Med. Cell. Longev., 2012, 2012, 132146.
89. Klimkowicz-Mrowiec, A., Bodzioch M, Szczudlik A, Slowik A. Clinical presentation of early-onset Alzheimer's disease as a result of mutation in exon 12 of the PSEN-1 gene. Am. J. Alzheimers Dis. Other Demen., 2014, 29(8), 732-4. http://dx.doi.org/10.1177/1533317514536599.
90. Nygaard, H.B., Lippa, C.F., Mehdi, D., Baehring, J.M. A Novel Presenilin 1 Mutation in Early-Onset Alzheimer's Disease With Prominent Frontal Features. Am. J. Alzheimers Dis. Other Demen., 2014, 29(5), 433-435. http://dx.doi.org/10.1177/1533317513518653.
91. Kukreja, L., Kujoth, G.C., Prolla, T.A., Van Leuven, F., Vassar, R. Increased mtDNA mutations with aging promotes amyloid accumulation and brain atrophy in the APP/Ld transgenic mouse model of Alzheimer's disease. Mol. Neurodegener., 2014, 9, 16. http://dx.doi.org/10.1186/1750-1326-9-16.
92. Damiano, M., Galvan, L., Déglon, N., Brouillet, E. Mitochondria in Huntington's disease. Biochim. Biophys. Acta, 2010, 1802(1), 52-61. http://dx.doi.org/10.1016/j.bbadis.2009.07.012.
93. Vonsattel, J.P., Myers, R.H., Stevens, T.J., Ferrante, R.J., Bird, E.D., Richardson, E.P. Jr. Neuropathological classification of Huntington's disease. J. Neuropathol. Exp. Neurol., 1985, 44(6), 559-77. http://dx.doi.org/10.1097/00005072-198511000-00003.
94. Yamamoto, A., Lucas, J.J. and Hen, R. Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease. Cell, 2000, 101(1), 57-66. http://dx.doi.org/10.1016/S0092-8674(00)80623-6.
95. Mochel, F. and Haller, R.G. Energy deficit in Huntington disease: why it matters. J. Clin. Invest., 2011, 121(2) 493-9. http://dx.doi.org/10.1172/JCI45691.
96. Damiano, M., Diguet, E., Malgorn, C., D'Aurelio, M, Galvan, L., Petit, F., Benhaim, L., Guillermier, M, Houitte, D, Dufour, N., Hantraye, P., Canals J.M., Alberch, J., Delzescaux, T., Déglon, N., Beal, M.F., Brouillet, E. A role of mitochondrial complex II defects in genetic models of Huntington's disease expressing N-terminal fragments of mutant huntingtin. Hum. Mol. Genet., 2013, 22(19), 3869-82. http://dx.doi.org/10.1093/hmg/ddt242.
97. Tsunemi, T., Ashe, T.D., Morrison, B.E., Soriano, K.R., Au, J., Roque R.A., Lazarowski, ER, Damian, V.A., Masliah, E., La Spada, AR PGC-1alpha rescues Huntington's disease proteotoxicity by preventing oxidative stress and promoting TFEB function. Sci. Transl. Med., 2012, 4(142), 142ra97. http://dx.doi.org/10.1126/scitranslmed.3003799.
98. Li X., Valencia, A., McClory, H., Sapp, E., Kegel, K.B., Difiglia, M. Deficient Rab11 activity underlies glucose hypometabolism in primary neurons of Huntington's disease mice. Biochem. Biophys. Res. Commun., 2012, 421(4), 727-30. http://dx.doi.org/10.1016/j.bbrc.2012.04.070.
99. Ribeiro, M., Rosenstock, T.R., Oliveira, A., Oliveira, C.R., Carvalho, R. A.C. Insulin and IGF-1 improve mitochondrial function in a PI-3K/Akt-dependent manner and reduce mitochondrial generation of reactive oxygen species in Huntington's disease knock-in striatal cells. Free Radic. Biol. Med., 2014, 74, 129-44. http://dx.doi.org/10.1016/j.freeradbiomed.2014.06.023